People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of ...

For millions of individuals managing Type 2 diabetes, every visit to the doctor carries the same concern; What do I do to ...

Amarin (AMRN) highlighted a new post hoc analysis of aspirin use in REDUCE-IT reinforcing that icosapent ethyl significantly ...

Efficacy of Icosapent Ethyl for Cardiovascular Risk Reduction by Aspirin Use in REDUCE-IT ...

Low-dose aspirin might help some people with type 2 diabetes avoid heart problems. Those with type 2 diabetes taking aspirin ...

Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.

People with type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...

Philip Morris International Inc. badly mismanaged and ultimately walked away from a lifesaving inhalable version of aspirin ...

People with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the ...